Supplementary Figure 4 from Sequential Immune Activation of Effector T Cells as Biomarkers of Response to Durvalumab in Patients with Locally Advanced NSCLC
Atsuto Mouri, Hirotsugu Kenmotsu, Hiroshi Kagamu, Koichi Azuma et autres
0 citations
Atsuto Mouri
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
162Publications signalées
1077Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
Cancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsLung Cancer Diagnosis and TreatmentColorectal Cancer Treatments and StudiesLung Cancer Research Studies
Publications récentes
Supplementary Figure 2 from Sequential Immune Activation of Effector T Cells as Biomarkers of Response to Durvalumab in Patients with Locally Advanced NSCLC
Atsuto Mouri, Hirotsugu Kenmotsu, Hiroshi Kagamu, Koichi Azuma et autres
0 citations
Supplementary Figure 3 from Sequential Immune Activation of Effector T Cells as Biomarkers of Response to Durvalumab in Patients with Locally Advanced NSCLC
Atsuto Mouri, Hirotsugu Kenmotsu, Hiroshi Kagamu, Koichi Azuma et autres
0 citations
Supplementary Figure 1 from Sequential Immune Activation of Effector T Cells as Biomarkers of Response to Durvalumab in Patients with Locally Advanced NSCLC
Atsuto Mouri, Hirotsugu Kenmotsu, Hiroshi Kagamu, Koichi Azuma et autres
0 citations
Supplementary Figure 6 from Sequential Immune Activation of Effector T Cells as Biomarkers of Response to Durvalumab in Patients with Locally Advanced NSCLC
Atsuto Mouri, Hirotsugu Kenmotsu, Hiroshi Kagamu, Koichi Azuma et autres
0 citations
Data from Sequential Immune Activation of Effector T Cells as Biomarkers of Response to Durvalumab in Patients with Locally Advanced NSCLC
Atsuto Mouri, Hirotsugu Kenmotsu, Hiroshi Kagamu, Koichi Azuma et autres
0 citations
Supplementary Figure 5 from Sequential Immune Activation of Effector T Cells as Biomarkers of Response to Durvalumab in Patients with Locally Advanced NSCLC
Atsuto Mouri, Hirotsugu Kenmotsu, Hiroshi Kagamu, Koichi Azuma et autres
0 citations
Supplementary Table 1 from Sequential Immune Activation of Effector T Cells as Biomarkers of Response to Durvalumab in Patients with Locally Advanced NSCLC
Atsuto Mouri, Hirotsugu Kenmotsu, Hiroshi Kagamu, Koichi Azuma et autres
0 citations
A Case of Tumor Embolism to the Lower Extremity Artery Caused by Pulmonary Sarcoma With Left Atrial Invasion
Tatsuhiko Uno, Kyoichi Kaira, Ou Yamaguchi, Kosuke Hashimoto et autres
0 citationsClinical Case Reports
Phase I and Early Phase II Study of Enhancing Immune Checkpoint Inhibitor Efficacy Using a Mycobacterium tuberculosis Extract Combined with Radiation Therapy in Non-Small Cell Lung Cancer Patients: NEJ046A
Atsuto Mouri, Jun Sugisaka, Yu Miura, Taku Nakagawa et autres
0 citationsSSRN Electronic Journal
Figure S1,S2,S3,S4,S5,S6,S7,S8,S9 and S10 from Single-Cell Analysis Reveals a CD4+ T-cell Cluster That Correlates with PD-1 Blockade Efficacy
Hiroshi Kagamu, Satoshi Yamasaki, Shigehisa Kitano, Ou Yamaguchi et autres
0 citations
Table S2, S4, S5, S6 and S7 from Single-Cell Analysis Reveals a CD4+ T-cell Cluster That Correlates with PD-1 Blockade Efficacy
Hiroshi Kagamu, Satoshi Yamasaki, Shigehisa Kitano, Ou Yamaguchi et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.